e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Lung morbidity on exposure to various agents
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Factors affecting mortality and morbidity in patients with bronchiectasis
S. Savas Bozbas, G. Ulubay, B. Akinci Ozyurek, E. Bozkurt Yilmaz, S. Akcay, F. Oner Eyuboglu (Ankara, Turkey)
Source:
Annual Congress 2010 - Lung morbidity on exposure to various agents
Session:
Lung morbidity on exposure to various agents
Session type:
Thematic Poster Session
Number:
4467
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Savas Bozbas, G. Ulubay, B. Akinci Ozyurek, E. Bozkurt Yilmaz, S. Akcay, F. Oner Eyuboglu (Ankara, Turkey). Factors affecting mortality and morbidity in patients with bronchiectasis. Eur Respir J 2010; 36: Suppl. 54, 4467
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Study of the factors affecting the morbidity and mortality of the patients of bilateral haemorrhagic pneumonia
Source: Annual Congress 2009 - Intensive care unit management and outcome
Year: 2009
Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis.
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
Factors affecting survival of bronchiectasis patients
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008
COPD the unseen factor causing increased morbidity and mortality among IHD patients
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009
Risk factors of mortality in COPD patients with ventilator associated pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 50s
Year: 2007
Survival and predictive factors of mortality in patients with bronchiectasis
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
Source: Eur Respir J, 56 (3) 2002961; 10.1183/13993003.02961-2020
Year: 2020
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
Source: Eur Respir J, 56 (3) 2002439; 10.1183/13993003.02439-2020
Year: 2020
Analysis of causes of death and mortality risk factors in elderly patients hospitalized due to pneumonia
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Factors affecting one year mortality of hospitalized patients with COPD exacerbation and respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 321s
Year: 2007
Risk factors for mortality in patients with COPD exacerbation
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
Source: Eur Respir J 2009; 34: 843-849
Year: 2009
Factors associated with community-acquired pneumonia in-hospital mortality in Portugal
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013
Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
Factors associated with recurrent admissions for bronchiectasis exacerbation in Asians
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept